Lv2
106 积分 2025-07-09 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
11天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
11天前
已完结
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
11天前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
11天前
已关闭
关于心室复极顺序的错误表述——浅谈心室除复极过程与QRS-T同向机制
3个月前
已关闭
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro
8个月前
已完结
Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reaction
8个月前
已完结
Probing the mechanism of insulin aggregation during agitation
8个月前
已完结
Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions
10个月前
已完结
皖公网安备34019202002308
